In the medical literature, hundreds of prediction models are being developed to predict health outcomes in individuals. For continuous outcomes, typically a linear regression model is developed to predict an individual's outcome value conditional on values of multiple predictors (covariates). To improve model development and reduce the potential for overfitting, a suitable sample size is required in terms of the number of subjects (n) relative to the number of predictor parameters (p) for potential inclusion. We propose that the minimum value of n should meet the following four key criteria: (i) small optimism in predictor effect estimates as defined by a global shrinkage factor of ≥0.9; (ii) small absolute difference of ≤ 0.05 in the apparent and adjusted R 2 ; (iii) precise estimation (a margin of error ≤ 10% of the true value) of the model's residual standard deviation; and similarly, (iv) precise estimation of the mean predicted outcome value (model intercept). The criteria require prespecification of the user's chosen p and the model's anticipated R 2 as informed by previous studies. The value of n that meets all four criteria provides the minimum sample size required for model development. In an applied example, a new model to predict lung function in African-American women using 25 predictor parameters requires at least 918 subjects to meet all criteria, corresponding to at least 36.7 subjects per predictor parameter. Even larger sample sizes may be needed to additionally ensure precise estimates of key predictor effects, especially when important categorical predictors have low prevalence in certain categories.
In the medical literature, hundreds of prediction models are being developed to predict health outcomes in individuals. For continuous outcomes, typically a linear regression model is developed to predict an individual's outcome value conditional on values of multiple predictors (covariates). To improve model development and reduce the potential for overfitting, a suitable sample size is required in terms of the number of subjects (n) relative to the number of predictor parameters (p) for potential inclusion. We propose that the minimum value of n should meet the following four key criteria: (i) small optimism in predictor effect estimates as defined by a global shrinkage factor of ≥0.9; (ii) small absolute difference of ≤ 0.05 in the apparent and adjusted R 2 ; (iii) precise estimation (a margin of error ≤ 10% of the true value) of the model's residual standard deviation; and similarly, (iv) precise estimation of the mean predicted outcome value (model intercept). The criteria require prespecification of the user's chosen p and the model's anticipated R 2 as informed by previous studies. The value of n that meets all four criteria provides the minimum sample size required for model development. In an applied example, a new model to predict lung function in African-American women using 25 predictor parameters requires
INTRODUCTION
Each year in the medical literature, hundreds of prediction models are developed to predict health outcomes in individuals. [1] [2] [3] Such models estimate an individual's predicted risk (for binary or categorical outcomes) or their expected outcome value (for a continuous outcome), conditional on the individual's observed value of multiple predictors. In this article, we focus on multivariable prediction models for continuous outcomes (eg, blood pressure, birth weight, depression score), which are typically developed using linear regression. This provides an equation containing an intercept term and multiple predictor effects (corresponding to mean differences), which is then used in new individuals to predict their expected outcome value. Predictors (also known as variables, covariates, or prognostic factors 4 ) typically include standard characteristics, such as age and stage of disease, or increasingly, biomarkers and genetic information.
Prediction models for continuous outcomes can potentially inform healthcare decisions and patient management, for example, to help decide on treatment and monitoring strategies. 1 Therefore, when developing their model, researchers should strive to use high quality datasets that allow a reliable model to be produced. This includes ensuring that the dataset has a suitable sample size. In particular, the number of subjects should be large enough relative to the number of predictor parameters to be estimated; otherwise, overfitting may be a serious problem. Overfitting refers to when a model is capturing idiosyncrasies in the development data; this leads to optimism in predictive performance such that the apparent performance is too high for the underlying population from which the development sample is drawn. 5 For example, in the development dataset, the developed model's apparent proportion of variation explained (R 2 ) will often be too high, and the model's predicted outcome values will often be too extreme (ie, pushed too far from the mean). Therefore, it is good practice to ensure that sample sizes are large enough to minimize this problem. 3 In this article, we build on the previous work of Harrell et al 3, 6 to propose how to calculate a suitable sample size for development of a prediction model using linear regression. Specifically, we suggest that the minimum sample size required should minimize the potential for overfitting (and therefore optimism) and ensure precise estimates of key model parameters. We propose four criteria, ie, (i) small optimism in predictor effect estimates; (ii) small absolute difference in the apparent and adjusted R 2 ; (iii) precise estimation of the residual standard deviation; and (iv) precise estimation of the mean predicted outcome value (model intercept when predictors are mean-centered). The number of subjects that meets all four criteria provides the minimum sample size required for model development.
The paper outline is as follows. In Section 2, we provide formulae to calculate the sample size required to meet criterion (i) and (ii), conditional on the user prespecifying the number of predictor parameters (p) and the model's anticipated proportion of variation explained (R 2 ), as informed by previous studies. Criteria (iii) and (iv) are then described in Section 3, and we show how to calculate sample sizes that ensure a small margin of error in the estimates, such as within 10% of their true values. Section 4 then provides an example to illustrate the approach. Section 5 briefly mentions that additional criteria may be important, such as precise estimation of predictor effects, and Section 6 concludes with discussion. A subsequent paper extends the ideas to binary and time-to-event models, such as logistic and Cox regression. 
SAMPLE SIZE REQUIRED TO MINIMIZE OVERFITTING AND OPTIMISM
To adjust for overfitting during model development, statistical methods for penalization of predictor effect estimates are available, where regression coefficients are shrunk toward zero from their usual estimated value (eg, from traditional maximum likelihood estimation). There are many options for shrinkage, 8 including a global shrinkage factor (sometimes referred to as a uniform shrinkage factor) that is derived and applied postestimation, 9, 10 or more holistic options such as ridge regression, elastic net, and the Lasso, which operate during the estimation process. 11, 12 However, the penalization factors used within these methods are often estimated with large uncertainty, which increases as the magnitude of overfitting increases. Van Houwelingen notes that, " … shrinkage works on the average but may fail in the particular unique problem on which the statistician is working."
8 Therefore, it is important to minimize the potential for overfitting. In this section, we outline how researchers can target a sample size (n) to minimize the potential for overfitting in advance of model development. Our formula is motivated by the concept of a global shrinkage factor, and so we begin by introducing this.
Global shrinkage factor
Consider a continuous outcome (Y i ), for i = 1 to n subjects (participants) in a study, to which we want to fit a linear regression model of the form
Assume that the unknown parameters of the equation (ie, the s and 2 ) are estimated using the data, usually, via ordinary least squares or maximum likelihood estimation. The intercept term, ie, , is the true mean outcome value for individuals whose X values are all zero, and each X term denotes values of included predictors. For example, X 1i could be the age of the subject in years, X 2i could be 1 for males and 0 for females, and so on. Each denotes the change in mean outcome value (ie, the mean difference) for each 1-unit increase in the corresponding predictor, after adjusting for other predictors. The error term, ie, e i , represents the residuals, and these are assumed to follow a normal distribution with a mean of zero and variance of 2 .
After fitting this regression model using traditional methods (eg, ordinary least squares), to adjust for overfitting a global (uniform) shrinkage factor (S) can be applied to all estimated predictor effects (̂1,̂2,̂3, etc). That is, when making predictions in new individuals, we can use the modified equation of
where * is the revised intercept, which is re-estimated to ensure the overall predicted mean agrees with the observed mean in the development dataset (for details on how to do this, see Table 1 and the work of Harrell 3 ). Compared to the original (nonpenalized) model, this will shrink predicted values in new individuals away from the extremes and move them toward the mean.
Implementation of this global shrinkage approach requires S to be estimated. A popular approach postestimation is bootstrapping. 13 An alternative is to utilize the closed-form solution of Copas 10,14
which, for linear regression (see equation (8.5) in the Copas paper 10 ), provides an unbiased estimate of the shrinkage factor. Here, p is the total number of predictor parameters (assumed ≥2) and LR is the likelihood ratio (chi-squared) statistic for the model, which can be defined as
where ln L null is the log-likelihood of a model with no predictors (ie, intercept-only null model), and lnL model is the log-likelihood of the final developed model. In Section 2.2, we also show how LR can be expressed in terms of R 2 (see Equation (5)). This shrinkage estimate of S C relates to a model developed without any variable selection procedure, and thus p represents the entire set of predictor parameters in the model. When selection procedures are used during model development, p will be closer to the number of parameters based on the entire set of candidate predictors (ie, all those considered for inclusion, regardless of whether they were all included in the final model). 3 Therefore, we generally define p as the total number of predictor parameters considered within the model development. Note that, if a predictor is categorical with three of more categories, or continuous and modeled as a nonlinear trend, then it will contribute two or more parameters. For these reasons, we refer to subjects per predictor parameter, rather than subjects per variable, in this article. Example of a global shrinkage factor. For illustration, we used data from a randomized trial of 262 hypertension patients to develop a linear regression model for predicting systolic blood pressure (SBP) at the end of treatment. 15 We forced inclusion of seven predictors, ie, age, sex, treatment group (treatment/control), smoker (yes/no), body mass index (BMI), baseline SBP, and baseline diastolic blood pressure (DBP). These correspond to seven predictor parameters (ie, p = 7). The model parameter estimates are shown in Table 1 , and the LR statistic was 69.295. The corresponding global shrinkage factor estimate from Equation (3) is
We also used 5000 bootstrap samples to estimate the global shrinkage factor (as described elsewhere 5, 16 ), and this gave a very similar value of 0.94. Furthermore, the adjusted R 2 was 0.21, which is about 0.91 times the apparent R 2 value of 0.23. Therefore, even though there was no automated predictor selection based on p-values, there is still some evidence of overfitting (and thus optimism in apparent predictive performance). For a more robust prediction of SBP in new individuals, Table 1 also shows the original beta coefficients multiplied by 0.928, which shrink the model's predictions toward the overall mean.
Shrinkage expressed in terms of sample size and R 2
We now propose utilizing the Copas shrinkage factor, ie, S C , to inform sample size calculations at the start of a study, ie, before individual participant data have been obtained. Specifically, we derive an expression that allows the researcher to identify the sample size and number of predictor parameters that gives an expected value of S C close to 1 (eg, 0.9). Our approach specifically builds on the work of Harrell et al, 3, 6 who shows how (after the development dataset is obtained and a model fitted including all predictors) the shrinkage estimate can inform whether to reduce the number of predictors (using so-called data reduction techniques). Our premise is the same, except we focus on calculating the expected shrinkage before data collection to inform sample size calculations for a new study.
We start by re-expressing S C in terms of sample size ( n), number of predictor parameters ( p), and R 2 , the proportion of variability explained. Let R 
Applying Equation (5) within Equation (3), the Copas shrinkage formula becomes
Equation (6) cannot be used to directly inform the sample size (n) in advance of model fitting because R 2 app is a postestimation measure of model fit. However, an approximately unbiased (optimism-adjusted) estimate of the proportion of variation explained is R 2 adj , 10,19 ie,
and rearranging gives
Therefore, applying Equation (8) within Equation (6) provides
Hence, we now have an expression for the expected shrinkage factor conditional on a particular R 2 adj and, crucially, the sample size (n), and number of predictor parameters (p). When studying Equation (9), we observe that the expected shrinkage will decrease (ie, S C will move closer to 1) as n increases, as p decreases, as n/p increases, and as R 2 adj increases. Therefore, shrinkage (overfitting) will be a larger concern in development datasets with a small number of subjects, a large number of predictor parameters (relative to the number of subjects), and when the proportion of variance explained by the model is low.
Criterion (i):
calculating sample size to ensure a shrinkage factor ≥ 0.9
Recall, at the start of Section 2, we explained that it is important to minimize the potential for overfitting. Therefore, when designing a new model development study, we propose researchers should utilize Equation (9) to reveal the sample size (n) needed to obtain a targeted value of S C . We suggest using a value of S C ≥ 0.9, such that predictor effects would shrink by ≤ 10%, which represents small overfitting. This is in accordance with the work of Harrell, 3 who suggests that, if the shrinkage estimate "falls below 0.9, for example, we may be concerned with the lack of calibration the model may experience on new data."
Although there is no closed-form solution for n based on Equation (9), an iterative process can be used to identify the value of n that gives the desired S C conditional on a chosen p and R 2 adj . For example, to obtain an expected S C of 0.9 for a hypothetical model with up to 30 predictor parameters and an anticipated R 2 adj of 0.7, a sample size of 206 subjects is required to meet criterion (i) as follows:
This equates to 206/30 = 6.87 subjects per predictor parameter; that is, about 6.87 subjects are required for each predictor parameter considered. If it was rather considered that up to 50 predictor parameters are needed for an anticipated R 2 adj of 0.7, then a sample size of 355 subjects is required to obtain an expected S C of 0.9, corresponding to 7.10 subjects per predictor parameter. Hence, the number of subjects per predictor parameter changes depending on the number of predictor parameters considered.
In situations where the calculated sample size is considered unrealistic (eg, due to time and cost constraints), p could be lowered by reducing the number of candidate predictor parameters. For example, those predictors known from previous studies (or systematic reviews) to have predictive value could be prioritized, or two or more predictors could be combined into one, such as BMI instead of weight and height. Alternatively, after data collection, unsupervised learning techniques such as principal component analysis could be used, which are blind to the outcome values. In the aforementioned example, reducing the number of predictor parameters to 25 leads to a sample size of 169 subjects to meet criterion (i)
Thus, by removing five predictor parameters, the required sample size to meet criterion (i) is reduced by 37 subjects. When using a more stringent shrinkage factor, say of 0.95, then the necessary sample size to meet criterion (i) will be increased substantially. For instance, in the previous example with 25 predictor parameters and an anticipated R 2 adj of 0.7, the sample size required is increased from 169 to 361 when increasing S C from 0.90 to 0.95. Hence, over twice the sample size is needed to reduce the expected shrinkage from 10% to 5%. For this reason, we anticipate that an S C of 0.90 will often be a pragmatic choice for criterion (i). Criterion (i) focuses on shrinkage of predictor effects, which is a multiplicative measure of overfitting (ie, on the relative scale), and therefore Harrell also suggested to evaluate overfitting on the absolute scale. 3 To address this, our second criterion for minimum sample size is to ensure that the difference ( ) between R 
After rearranging this solution, we find that, to meet criterion (ii), we require the number of subjects to be
where is a small value, such as ≤ 0.05. For example, returning to our hypothetical model with an anticipated R 2 adj of 0.7 and up to 30 potential predictor parameters, the sample size required to meet criterion (ii) is as follows:
This is slightly lower than the sample size of 206 identified for criterion (i) in Section 2.3. Equation (10) reveals that, similar to the shrinkage approach for criterion (i), the required sample size for criterion (ii) will increase as p increases and R 
How to prespecify R adj
To identify a sample size to meet our criteria (i) and (ii), researchers have to prespecify a value for the model's anticipated R 2 adj . How should this be done? We recommend identifying previous prediction model studies for the same or similar populations and outcomes of interest and extracting their R 2 adj values, which are usually well reported for linear regression models. Helpful for this purpose are systematic reviews of existing models 20 and registries that record the prediction models available in a particular field. 21 If only an R 2 app value is reported in a model development study, then its R 2 adj can be derived using Equation (7) as long as the study's n and p can also be obtained. Note that, if R based on a reported R 2 app is necessary when the latter is from a model development study, but not when it is from an appropriate external validation study of an existing model. 5 Guidance for choosing an R 2 adj value in the absence of any prior information is given in the Discussion section.
SAMPLE SIZE REQUIRED FOR PRECISE ESTIMATION OF THE RESIDUAL STANDARD DEVIATION AND MEAN PREDICTED OUTCOME VALUE
In addition to reducing the potential for overfitting, Harrell noted that sample sizes should be large enough to precisely estimate key model parameters such as the intercept or residual variance. 3 We now address this.
Criterion (iii): precise estimate of the residual standard deviation
A precise estimate of the residual standard deviation is essential, as it is subsequently used to estimate R 2 , and also to derive the standard errors and confidence intervals for the intercept and predictor effects (betas). For simplicity, Harrell suggested focusing on the standard deviation, ie, null , say, in a null model (ie, intercept-only model), 3 and ensuring the lower and upper bounds of a 95% confidence interval for null have a small multiplicative margin of error (MMOE) around the true value of null . Assuming residuals are approximately normally distributed, this approach can be extended to consider the MMOE for estimating model , the residual standard deviation in the developed prediction model, by of being less than the critical value. The second term within the bracket of Equation (11) will typically give the largest MMOE.
For example, consider that we wish to ensure (with 95% confidence) that the margin of error is within 20% of the true value, ie, 1.0 ≤ MMOE ≤ 1.2. For a null model (ie, one containing no predictors), then Equation (11) reveals that a sample size of at least 70 subjects is needed to meet this criterion, 3 as this gives an MMOE of 1.2. Therefore, in a multivariable model with p predictor parameters, the minimum sample required to meet an MMOE ≤ 1.2 for criterion (iii) is simply 70 + p.
However, we recommend a more stringent margin of error of within 10% of the true value, ie, 1.0 ≤ MMOE ≤ 1.1. In a null model, Equation (11) reveals that a sample size of at least 234 subjects is needed to ensure an MMOE ≤ 1.1. Therefore, in a multivariable model with p predictor parameters, the minimum sample required to meet an MMOE of ≤
for criterion (iii) is simply 234 + p.
To illustrate this, let us return to the hypothetical example initially described in Section 2.3, where the sample size to meet criterion (i) was 206 and for criterion (ii) was 181. However, these values correspond to an MMOE of greater than 1.1 for model . For example, taking the sample size of 206 subjects and 30 predictor parameters, this corresponds to a Rather, with 30 predictor parameters, to achieve an expected MMOE of 1.1, we require 234 + p = 234 + 30 = 264 subjects because the maximum value of Equation (11) Hence, in this example, the minimum sample size of 264 subjects for criterion (iii) (ie, to ensure an MMOE ≤1.1) is more stringent than those identified for criteria (i) and (ii).
Criterion (iv): precise estimate of the mean predicted outcome value (model intercept)
It is also important for model predictions to be precise; in particular, it is fundamental that the mean predicted outcome value is precisely estimated. If we assume our model will include predictors centered at their mean values in the developed dataset, then the fitted model's intercept (̂m odel ) will correspond to the predicted outcome value for an individual with mean predictor values. This estimate will be similar (though not identical) to the overall mean outcome in the population of interest; such a population mean estimate has variance of̂2 null ∕n. However, in a linear regression model with multiple predictors the residual variance iŝ2 model , and so the fitted model's intercept will have an approximate variance of * var (̂m odel ) =̂2 model ∕n ≈ Then, a 95% confidence interval for the model intercept iŝ
where t 1−
2
,n−p−1 is the critical value of a t-distribution with n − p − 1 degrees of freedom for which there is a probability of 1 − 0.05 2 below the critical value. Therefore, to derive this confidence interval in advance of model development, the researcher needs to prespecify (eg, from previous studies) sensible values for the anticipated mean outcome value (̂m odel ), the population (null model) variance ( 2 null ), and R 2 adj . Then, the researcher can identify the sample size that ensures a sufficiently narrow confidence interval for model to satisfy criterion (iv). For example, they might ensure the lower and upper bounds are within a small MMOE of the anticipated prediction mean (ie, 1.0 ≤ MMOE ≤ 1.1) .
However, what constitutes a sufficiently narrow confidence interval will be context specific. A sensible start point is to examine the confidence interval width when using the sample sizes identified for criterion (i) to (iii). For example, let us return to our hypothetical model with an anticipated R 2 adj of 0.7 and p = 30 predictor parameters, and now assume that the target population has an anticipated mean blood pressure (̂m odel ) of 165 and variance (̂2 null ) of 18 2 . Then, using Equation (12) This is reassuringly precise, with the upper bound just 1.2 higher than the true mean of 165; this corresponds to a margin of error within 10% of the true mean (indeed, MMOE is 166.2/165 = 1.007, and thus margin of error < 1%).
WORKED EXAMPLE: PREDICTION OF LUNG FUNCTION IN AFRICAN-AMERICANS
A step-by-step summary of our sample size proposal is given Figure 1 , and we now apply it to a worked example. Kumar et al use linear regression to identify predictors of lung function (ie, the forced expiratory volume in 1 second, FEV1) in African-American participants. 22 Let us assume that we want to build on this work by formally developing a linear regression model to predict FEV1 in African-American women. The aim could be to flag those individuals with low FEV1 values, as these are at risk of chronic obstructive pulmonary disease. We now go through the sample size calculation process. was on average about 0.2 across three different datasets. Therefore, we could use this value as a lower bound for the anticipated R 2 adj in the new model. Furthermore, let us assume that there will be up to 25 predictor parameters in this new model (including the four used in the original model), and thus p = 25.
Step-by-step application
Step 3: Criterion (i) -ensuring S C is close to 1. Based on the chosen R 2 adj = 0.2 and p = 25, to ensure an expected S C of 0.9, a sample size of 918 subjects is needed because (using equation (9))
))
= 0.90.
FIGURE 1 Summary of the steps involved in our sample size calculation for developing a multivariable prediction model
This corresponds to requiring 36.7 subjects per predictor parameter to meet criterion (i). Figure 2 shows how the expected shrinkage (S C ) derived from Equation (9) changes according to n and p, conditional on an R 2 adj of 0.2. As n increases and p decreases, the expected S C becomes closer to 1. Furthermore, for an S C above 0.9, very large increases in the sample size are needed to improve the expected S C . For example, if we wanted to use a more stringent criteria for low overfitting of S C = 0.95, then a sample size of 1949 subjects is required (78 subjects per predictor parameter), which is over double the number when S C is 0.9. Step 4: Criterion (ii) -ensuring small absolute difference between R adj and R app . Using Equation (10), we can calculate the minimum sample size needed to ensure the absolute difference between R 2 adj and R 2 app is 0.05 or less
Therefore, at least 401 subjects are required to ensure a small absolute magnitude of overfitting based on the difference between R 2 adj and R 2 app .
Step 5: Criterion (iii) -ensuring a precise estimate of the residual standard deviation. When p = 25, then Equation (11) reveals that we need at least 259 subjects (= 234 + p) to ensure a margin of error of ≤ 10% in the estimate of the model's residual standard deviation, ie, model . This is because the maximum value of Equation (11) Step 6: Criterion (iv) -ensure a precise estimate of the mean predicted outcome (model intercept). Based on the results in Kumar et al, 22 the population mean and variance of FEV1 are about 1.90 liters and 0.6, 2 respectively. Based on these values and using Equation (12) with an assumed sample size of 918 subjects (as needed for criterion (i)), we obtain a 95% confidence interval for the predicted mean outcome value (model intercept when predictors are mean-centered) of This is reassuringly precise, and the upper bound indicates an MMOE < 1.1 (ie, within 10%) of the true mean outcome value.
Step 7: Identify sample size that ensures all criteria are met.
Based on the largest sample size calculations identified in steps 3 to 6, the final minimum sample size required is 918 subjects. This is driven by criterion (i) to ensure an expected shrinkage factor ≥ 0.9.
What if the sample size is not considered achievable?
If the sample size of 918 subjects was not considered achievable (eg, due to time or cost constraints), then what should be done? For criterion (i), we do not recommend reducing S C below 0.9, as our main premise is to minimize overfitting. That leaves two other potential options; either use a larger R 
Therefore, the best approach is to reduce the number of candidate predictor parameters, ie, p. Returning to the hypothetical example where the assumed R 2 adj is 0.2, a reduced set of 15 predictor parameters would lower the sample size required for criterion (i) to 515 subjects (Figure 2) . Thus, after sacrificing 10 parameters by removing some predictors, the researchers requires 403 fewer subjects to target an S C of 0.9. The choice of which predictors to prioritize could be based on external evidence (eg, from systematic reviews) and, after data collection, data reduction techniques such as principal components analysis (which are based on observed correlation among predictors only, and not observed predictor-outcome associations). All those predictors within the existing Kumar et al model are best retained in the model to justify the assumption that R 2 adj is at least 0.2. A sample size of 515 subjects still ensures that criteria (ii) to (iv) are met. For example, for criterion (iv), the width of the 95% confidence interval for the prediction mean would still be very narrow (1.85 to 1.95).
Comparison to other suggested sample size proposals
We now contrast our derived sample size of 918 subjects to those from two other suggested sample size approaches for linear regression models. Though not intended for informing prediction model development, a recent recommendation suggests two subjects per predictor parameter for adequate estimation of predictor effects in linear regression. 23 In our example, two subjects for each of the 25 predictor parameters leads to a substantially smaller sample size of 50 subjects. However, using Equation (9), this corresponds to an expected shrinkage of S C = 0.51, which reflects substantial overfitting and does not meet criterion (i) (Figure 2) .
Alternatively, Harrell suggests that there are at least 15 subjects per predictor parameter (see Chapter 4 in his book 3 ), which in this example implies a sample size of at least 375. However, using Equation (9), a sample size of 375 subjects corresponds to an expected shrinkage of S C = 0.79, which still suggests large overfitting.
POTENTIAL ADDITIONAL CRITERIA
Criteria (i) to (iv) form our main proposal for the minimum sample size required when developing a prediction model for continuous outcomes. However, we now briefly mention two additional criteria that may also be important to consider.
Ensuring precise estimation of R adj and the mean-square error
Criterion (ii) ensures that there is a small absolute difference between R 2 adj and R 2 app to reflect low overfitting. A related concept is to ensure a precise confidence interval for R 2 adj . 24 Tan gives an excellent overview of various exact and approximate approaches to calculate a confidence interval for R 2 adj , 25 given a developed model's R 2 app , n, and p. For example, Lee proposes a confidence interval based on a scaled noncentral F distribution approximation to the distribution of R 2 . 26 This can be implemented in SAS, 27 or in R using the ci.R2 function of the MBESS package by Kelley. [28] [29] [30] Furthermore, the ss.aipe.R2 function within MBESS identifies the sample size required to ensure Lee's confidence interval is sufficiently narrow.
We applied the ss.aipe.R2 function to the lung function model described in Section 4. This identified that 835 subjects are required to ensure the expected width of the confidence interval for R 2 adj is exactly 0.10, assuming R 2 adj is 0.20 and p = 25. This sample size is lower than the 918 subjects required to meet criterion (i), and hence 918 subjects is still the minimum sample size required.
Ensuring precise estimates of R 
Ensuring precise estimation of key predictor effects
Criterion (iv) ensures a precise estimate of the mean predicted outcome value in the entire target population. Ideally, predictions should also be precise across the entire spectrum of predicted values, not just at the mean. This is challenging but is helped by ensuring the effects of key predictors are estimated precisely. The precision of a particular predictor effect in a fitted linear regression model depends on the sample size, the estimated residual variance, the correlation of the predictor with other included predictors, and the variance of the predictor values. 31 For brevity, we do not consider this in detail here and refer the reader to other articles that focus on this. [31] [32] [33] [34] [35] In particular, the ss.aipe.rc function with the MBESS package identifies the sample size required to ensure the confidence interval around a predictor's effect is sufficiently narrow. 30, 33, 35 Returning to the lung function example, let us consider that our new model will potentially include smoking as a predictor, defined as a binary variable (current/previous smokers versus nonsmokers). Furthermore, assume that the mean difference in FEV1 for smokers and nonsmokers is −0.5, and that (based on the work of Kumar et al 22 ) 50% of subjects will be current/previous smokers. Moreover, assume (conservatively) that the final model will have R 2 adj of 0.2 and that the correlation is 0.5 between smoking and other included predictors. Using the ss.aipe.rc function in R, we identify that 619 subjects are required to ensure a confidence interval width of 0.2 (and thus the lower and upper bounds are within 0.1 of the true value of −0.5). This is reassuring, and again, less than the 918 subjects are required to satisfy criterion (i).
Precise estimation of predictor effects will be especially difficult for those predictors with the smallest variance in their values, as their confidence intervals are likely to be the widest. 31 In particular, categorical predictors with low prevalence in certain categories have small variances. 36 In our example, had we assumed that the percentage of smokers was 10%, rather than 50%, then repeating the calculation identifies that 1668 subjects are needed for a confidence interval width of 0.2. In this situation, we would need to increase the sample size beyond 918 subjects previously identified to meet criteria (i) to (iv) or justify relaxing the magnitude of precision desired. For example if we were willing to widen the expected confidence interval width to 0.3, then this considerably reduces the number of the required subjects to 757, but the interval is still fairly precise and all well below zero (−0.65 to −0.35).
DISCUSSION
Sample size calculations are a fundamental part of designing a study to develop a new prediction model. In this article, we proposed four criteria to identify the minimum sample size needed to minimize overfitting while ensuring precise estimates of key model parameters. Criterion (i) forms the most novel aspect of our sample size proposal, as it allows researchers to identify n and p that correspond to an expected shrinkage factor close to 1, such as 0.9, which reflects low overfitting. Furthermore, it allows the sample size to be tailored to each model of interest through the prespecification of the anticipated proportion of variation explained, ie, R 2 adj , which is a measure of overall model fit. The chosen value of R 2 adj strongly influences the amount of shrinkage required, with larger values requiring less shrinkage (with other things, such as p, being equal). 37 This issue is currently ignored when using blanket rules of thumb for sample size. Researchers should use previous evidence from other prediction model's in the same setting to ascertain a (conservative) value for the new model's potential R 2 adj value. If no relevant prediction models exist, then information from predictor finding studies (ie, studies aiming to estimate the prognostic effect of a particular predictor adjusted for other existing factors 4 ) might be relevant. Even though such studies are primarily focused on the estimation of the effect of a particular predictor, they typically involve multivariable modeling and therefore often also report R value, researchers should recognize that medical diagnosis and prediction of health-related outcomes are, generally speaking, low signal:noise ratio situations. It is not uncommon in these situations to see R 2 adj values in the 0.1 to 0.2 range. Therefore, in the absence of other information, we suggest that sample sizes be derived assuming that R 2 adj = 0.15. An exception is when predictors include "direct" (mechanistic) measurements, such as the baseline version of the continuous outcome (eg, when predicting lung function one year after measuring baseline lung function). Then, in this special situation, an R 2 adj = 0.5 may be a more appropriate default choice. In practice, after a model development dataset is obtained, a better approach for estimating the shrinkage factor is to use a resampling approach such as bootstrapping. 10, 16 However, as our sample size calculations are focused on situations before any data collection, it is not possible to incorporate such a resampling approach. In situations where a development dataset is already available, containing a specific number of subjects and predictors, our approach could be used to identify whether a reduction in the number of predictors is needed (prior to beginning the modeling). Indeed, Harrell previously illustrated this concept by using the shrinkage estimate from the full model (including all predictors) to gauge whether the number of predictors should be reduced. 3 This could then incorporate bootstrapping (rather than the Copas formula) to estimate the shrinkage. However, this should be done blind to the estimated predictor effects, as otherwise the decisions about inclusion are already being made based on the full set of predictors. Similarly, when planning to use a predictor selection method (such as backwards selection) during model development, researchers should define p as the total number of parameters due to all predictors considered (screened) and not just the subset that are included in the final model. 5 As Harrell notes, 3 the value of p should be honest. A potential limitation of our work is that multiple sample size calculations are required to address each of the criteria considered. However, this reflects the different elements that require consideration when developing a prediction model. Criteria (iii) and (iv) are needed to ensure that there will be a small margin of error in the estimates of the residual standard deviation and the mean predicted outcome value (model intercept). This is often overlooked when considering the sample size. In particular, at least 234 + p subjects are always required to ensure an MMOE of ≤ 1.1 for estimating the model's residual standard deviation, ie, model . Section 5 emphasized that further criteria may also be needed in some settings. In particular, ensuring precise estimates of predictor effects may be important, especially in settings where key predictors have low variance (eg, categorical predictors with few subjects in certain categories).
In summary, we have proposed how to ascertain the minimum sample size needed to develop a prediction model using linear regression. We hope this encourages researchers to move away from rules of thumb and to rather focus on attaining sample sizes that ensure precise estimates and reduce the potential for overfitting to develop more robust prediction models. We are currently writing software modules to implement the approach. Our accompanying paper extends the work to binary and time-to-event outcomes. 
